# Evaluation of Pretreatment Sarcopenia in Patients With Inoperable High-grade Ovarian Carcinoma as Part of Optimised Management

> **NCT05415527** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Institut Bergonié** · enrollment: 25 (actual)

## Conditions studied

- Ovarian Carcinoma

## Interventions

- **OTHER:** Presence of sarcopenia evaluated prior to neoadjuvant chemotherapy and during chemotherapy as part of optimised management(dietician and APA).

## Key facts

- **NCT ID:** NCT05415527
- **Lead sponsor:** Institut Bergonié
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-06-11
- **Primary completion:** 2027-06-10
- **Final completion:** 2028-06-10
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2026-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05415527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05415527, "Evaluation of Pretreatment Sarcopenia in Patients With Inoperable High-grade Ovarian Carcinoma as Part of Optimised Management". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05415527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*